Surgery Websites
Transplant Surgery »  Meet the Team »  Pediatric Hepatology »  Philip Rosenthal, M.D.
Philip Rosenthal, M.D.

Philip Rosenthal, M.D.

Professor of Pediatrics and Surgery
Director of Pediatric Hepatology Research
Director, Pediatric Hepatology
 

Contact Information

Academic Office
Room MU 415, Box 0136
University of California, San Francisco
San Francisco, CA 94143-0136
(415) 476-5892
(415) 476-1343 Fax
prosenth@peds.ucsf.edu
Open Popup
  • 1967-71 State Univ. of N.Y. at Albany, Albany, NY, B.S. Magna Cum Laude, Biology
  • 1971-75 State Univ. of N.Y. Downstate Med. Ctr. Brooklyn, NY, M.D. Magna Cum Laude
  • 1975-76 Albert Einstein/Bronx Mun. Hosp., NY, Intern Pediatrics
  • 1976-78 Albert Einstein/Bronx Mun. Hosp., NY, Resident Pediatrics
  • 1978-81 University of California, San Francisco, Fellow Pediatric Gastroenterology
  • American Board of Pediatrics, General Pediatrics
  • American Board of Pediatrics, Subspeciality in Pediatric Gastroenterology
  • American Board of Pediatrics, Certificate of Added Qualification in Transplant Hepatology
  • UCSF Helen Diller Family Comprehensive Cancer Center
  • UCSF Liver Center
  • Pediatric Liver Transplant Program
  • Pediatric Intestinal Rehabilitation and Transplantation Program
  • Bioartificial liver devices
  • Genetics and immunology of biliary atresia
  • Idiopathic neonatal hepatitis
  • Pediatric Acute Liver Failure (PALF)
  • Quality of life after liver transplants

Philip Rosenthal, M.D. is Professor of Pediatrics and Surgery, Medical Director of the Pediatric Liver Transplant Program. and Director of Pediatric Hepatology at UCSF.  Rosenthal completed his medical training at Downstate Medical Center and the Albert Einstein Medical Center in New York. He then completed a fellowship in pediatric gastroenterology at UCSF. He joined the UCSF faculty in 1995 after serving as Professor of Pediatrics at University of California, Los Angeles (UCLA). 

A  pediatric hepatologist at the UCSF Benioff Children's Hospital, Rosenthal is internationally renowned for the care of children with liver disease, including liver cancer, and  those undergoing liver transplantation. In addition, Rosenthal has and currently serves as Principal Investigator on numerous clinical trials to improve the care of patients with pediatric liver disease.

Rosenthal has won numerous honors for his research including work on the pharmaceutical treatment of hepatitis B and C, genetics and immunology of biliary atresia and the quality of life after liver transplants in children. He is a consultant to organizations such as the American Liver Foundation, Parents of Kids with Infectious Diseases, Alagille Syndrome Alliance, Studies of Pediatric Liver Transplantation (SPLIT), Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH). He is also on editorial boards and a regular reviewer for leading professional journals.

  • Murray Davidson Award, American Academy of Pediatrics, 2013
  • Chancellor's Award for Public Service, UCSF, 2002

Rosenthal is pursuing research on the pharmaceutical treatment of hepatitis B and C, genetics and immunology of biliary disease, use of bioartificial liver support utilizing porcine hepatocytes for patients with fulminant liver failure, as well as researching the quality of life following liver transplantation in children. 

Clinical Research

Rosenthal is principal investigator on numerous clinical trials including the following:

View all trials 

Most recent publications from a total of 202
  1. Arinaitwe E, Dorsey G, Nankabirwa JI, Kigozi SP, Katureebe A, Kakande E, Rek J, Rosenthal PJ, Drakeley C, Kamya MR, Staedke SG. Association between Recent Overnight Travel and Risk of Malaria: A Prospective Cohort Study at Three Sites in Uganda. Clin Infect Dis. 2018 Jun 04. View in PubMed
  2. Kortz T, Rosenthal PJ. Reconciling Conflicting Results From Pediatric Sepsis Studies: The Need for Context-Specific Sepsis Bundles. Pediatr Crit Care Med. 2018 Jun; 19(6):594-595. View in PubMed
  3. Schaub JR, Huppert KA, Kurial SNT, Hsu BY, Cast AE, Donnelly B, Karns RA, Chen F, Rezvani M, Luu HY, Mattis AN, Rougemont AL, Rosenthal P, Huppert SS, Willenbring H. De novo formation of the biliary system by TGFß-mediated hepatocyte transdifferentiation. Nature. 2018 May 02. View in PubMed
  4. Narkewicz MR, Horslen S, Hardison RM, Shneider BL, Rodriguez-Baez N, Alonso EM, Ng VL, Leonis MA, Loomes KM, Rudnick DA, Rosenthal P, Romero R, Subbarao GC, Li R, Belle SH, Squires RH. A Learning Collaborative Approach Increases Specificity of Diagnosis of Acute Liver Failure in Pediatric Patients. Clin Gastroenterol Hepatol. 2018 Apr 30. View in PubMed
  5. Harlow KE, Africa JA, Wells A, Belt PH, Behling CA, Jain AK, Molleston JP, Newton KP, Rosenthal P, Vos MB, Xanthakos SA, Lavine JE, Schwimmer JB. Clinically Actionable Hypercholesterolemia and Hypertriglyceridemia in Children with Nonalcoholic Fatty Liver Disease. J Pediatr. 2018 Apr 13. View in PubMed
  6. Bull LN, Pawlikowska L, Strautnieks S, Jankowska I, Czubkowski P, Dodge JL, Emerick K, Wanty C, Wali S, Blanchard S, Lacaille F, Byrne JA, van Eerde AM, Kolho KL, Houwen R, Lobritto S, Hupertz V, McClean P, Mieli-Vergani G, Sokal E, Rosenthal P, Whitington PF, Pawlowska J, Thompson RJ. Outcomes of surgical management of familial intrahepatic cholestasis 1 and bile salt export protein deficiencies. Hepatol Commun. 2018 May; 2(5):515-528. View in PubMed
  7. Publicover J, Gaggar A, Jespersen JM, Halac U, Johnson AJ, Goodsell A, Avanesyan L, Nishimura SL, Holdorf M, Mansfield KG, Judge JB, Koshti A, Croft M, Wakil AE, Rosenthal P, Pai E, Cooper S, Baron JL. An OX40/OX40L interaction directs successful immunity to hepatitis B virus. Sci Transl Med. 2018 Mar 21; 10(433). View in PubMed
  8. Savic RM, Jagannathan P, Kajubi R, Huang L, Zhang N, Were M, Kakuru A, Muhindo MK, Mwebaza N, Wallender E, Clark TD, Opira B, Kamya M, Havlir DV, Rosenthal PJ, Dorsey G, Aweeka FT. Intermittent Preventive Treatment for Malaria in Pregnancy: Optimization of Target Concentrations of Dihydroartemisinin-Piperaquine. Clin Infect Dis. 2018 Mar 14. View in PubMed
  9. Ng VL, Sorensen LG, Alonso EM, Fredericks EM, Ye W, Moore J, Karpen SJ, Shneider BL, Molleston JP, Bezerra JA, Murray KF, Loomes KM, Rosenthal P, Squires RH, Wang K, Arnon R, Schwarz KB, Turmelle YP, Haber BH, Sherker AH, Magee JC, Sokol RJ. Neurodevelopmental Outcome of Young Children with Biliary Atresia and Native Liver: Results from the ChiLDReN Study. J Pediatr. 2018 Mar 05. View in PubMed
  10. Verstraete SG, Wojcicki JM, Perito ER, Rosenthal P. Bisphenol a increases risk for presumed non-alcoholic fatty liver disease in Hispanic adolescents in NHANES 2003-2010. Environ Health. 2018 Feb 01; 17(1):12. View in PubMed
  11. View All Publications
Publications provided by UCSF Profiles, powered by CTSI at UCSF. View profile of Philip Rosenthal, M.D.
Please note: UCSF Profiles publications are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact CTSI for help.
  • Alfonso Garcia

    A Young Man Saves Teen's Life

    Alfonso Garcia was just like any other typical healthy and active 16-year-old. He dreamed of attending the U.S. Military Academy at West Point, boxing, and serving in the military like his two other brothers. Then, in January 2010, he suddenly started feeling sick. He became feverish, anemic, fatigued and jaundiced. Alfonso found out that he had Wilson's disease, a rare genetic disorder in which copper in the body isn't properly eliminated and instead accumulates, damaging the liver and nervous system. Alfonso and his family received a grave[...]
    Story Categories: Liver TransplantWilson Disease

Site Directory
    X